Download U6 RNAi Entry Vector (BLOCKiT)

Transcript
Troubleshooting, continued
Ligation and Transformation Reactions, continued
Problem
Few kanamycinresistant colonies
obtained on the
selective plate,
continued
Many clones contain
inserts with sequence
mutations
Poor sequencing
results
No colonies obtained
on the selective plate
Reason
Solution
Not enough transformation
mixture plated
Increase the amount of the transformation
mixture plated.
Selective plates contained too
much kanamycin
Use LB agar plates containing 50 µg/ml
kanamycin for selection.
Did not use the competent cells
supplied with the kit
Use the One Shot® TOP10 Chemically
Competent E. coli supplied with the kit; transformation efficiency is > 1 x 109 cfu/µg DNA.
Not enough of the ligation
reaction transformed
Increase the amount of ligation reaction
transformed.
Did not perform the 1 hour
grow-out period before plating
the transformation mixture
After the heat-shock step, add S.O.C. Medium
and incubate the bacterial culture for 1 hour at
37°C with shaking before plating.
Poor quality single-stranded
oligos used
•
Oligo preparation contains
mutated sequences
•
Use mass spectrometry to check for peaks
of the wrong mass.
•
Oligo preparation contains
contaminants
•
Order HPLC or polyacrylamide gel
(PAGE)-purified oligos.
•
Order oligos from Invitrogen’s custom
primer synthesis service (see our Web site
for more information).
Did not use the competent cells
supplied with the kit
Use the One Shot® TOP10 Chemically
Competent E. coli supplied with the kit; transformation efficiency is > 1 x 109 cfu/µg DNA.
Loss of sequencing signal in the
hairpin region due to secondary
structure formation
•
Use high-quality, purified plasmid DNA
for sequencing.
•
Add DMSO to the sequencing reaction to
a final concentration of 5%.
•
Increase the amount of template used for
sequencing (up to twice the normal
amount).
•
Use a 7:1 molar ratio of dITP:dGTP in
your sequencing reaction.
Used the wrong antibiotic for
selection
Select for transformants on LB agar plates
containing 50 µg/ml kanamycin.
continued on next page
32